Dicerna Pharmaceuticals, Inc. EBITDA Margin 2013-2021 | DRNA
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Dicerna Pharmaceuticals, Inc. (DRNA) over the last 10 years. The current EBITDA margin for Dicerna Pharmaceuticals, Inc. as of September 30, 2021 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2021-09-30 | $0.19B | $-0.11B | -58.55% |
| 2021-06-30 | $0.18B | $-0.12B | -65.92% |
| 2021-03-31 | $0.18B | $-0.11B | -64.04% |
| 2020-12-31 | $0.16B | $-0.11B | -67.68% |
| 2020-09-30 | $0.13B | $-0.12B | -93.08% |
| 2020-06-30 | $0.09B | $-0.13B | -148.31% |
| 2020-03-31 | $0.06B | $-0.13B | -229.09% |
| 2019-12-31 | $0.02B | $-0.13B | -541.67% |
| 2019-09-30 | $0.02B | $-0.11B | -573.68% |
| 2019-06-30 | $0.01B | $-0.10B | -730.77% |
| 2019-03-31 | $0.01B | $-0.10B | -1155.56% |
| 2018-12-31 | $0.01B | $-0.09B | -1137.50% |
